TabletsClinical Overview
Rebamipide Tablets (100mg) is an oral mucosal protective and cytoprotective antiulcer agent. It stimulates endogenous prostaglandin (PGE2 and PGI2) generation in gastric mucosa, promotes gastric mucus synthesis and blood flow, scavenges reactive oxygen species, and suppresses inflammatory cytokine expression. Indicated for gastric ulcers and improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in acute gastritis and acute exacerbation of chronic gastritis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 100 mg three times daily (morning, evening, and bedtime) with water, with or without food. Swallow whole. Usual treatment duration is 4 to 8 weeks.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Mild nausea, vomiting, heartburn, abdominal distension, diarrhea, transaminase rise. Rare/Severe: Leukopenia, thrombocytopenia, jaundice, and anaphylaxis.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with hypersensitivity to rebamipide. Caution in elderly patients. Discontinue if hepatic dysfunction or skin eruptions occur.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.